Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis: Optimizing treatment strategy].

Thierry Thomas1

  • 1Service de rhumatologie, Inserm E0366, Saint-Etienne (42). thierry.thomas@univ-st-etienne.fr

Presse Medicale (Paris, France : 1983)
|October 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Combination of Percutaneous Cryoablation, Screw Fixation, and Cementoplasty for Painful Pelvic Bone Metastases: A Supportive Care Approach Improving Pain, Mobility, and Quality of Life.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Early upper and lower limbs bone microarchitecture alterations evaluated by HR-PQCT after stroke with hemiplegia.

Joint bone spine·2025
Same author

Bone Health Following Lifestyle-Induced Weight Loss in Individuals With Overweight/Obesity: A Narrative Review.

Obesity (Silver Spring, Md.)·2025
Same author

Combination Therapy Using Embolization, Gelified Alcohol Sclerotherapy, and Vertebroplasty to Treat Aggressive Vertebral Hemangioma: Technique and Initial Results.

Journal of vascular and interventional radiology : JVIR·2025
Same author

Percutaneous Pelvic Cementoplasty With or Without Screw Fixation in Patients Aged 70 Years and Over: Safety and Clinical Outcomes.

Journal of vascular and interventional radiology : JVIR·2025
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Accurately assessing 10-year absolute fracture risk is crucial for selecting postmenopausal osteoporosis treatments. Treatment duration is 4-5 years, requiring risk reevaluation, and drug combinations are not advised.

Area of Science:

  • Gerontology
  • Endocrinology
  • Pharmacology

Context:

  • Postmenopausal osteoporosis management relies on accurate fracture risk assessment.
  • Key risk factors include DXA measurements, age, and other clinical indicators.
  • The primary objective is to mitigate fragility fracture risk.

Purpose:

  • To outline the principles for selecting postmenopausal osteoporosis treatments.
  • To emphasize the importance of comprehensive fracture risk evaluation.
  • To define optimal treatment duration and reevaluation protocols.

Summary:

  • Patient selection for osteoporosis treatment hinges on a 10-year absolute fracture risk assessment.
  • This assessment integrates DXA, age, and additional clinical risk factors.

Related Experiment Videos

  • Treatment choice is guided by drug efficacy from clinical trials and individual patient risk profiles.
  • A minimum treatment duration of 4-5 years is recommended, followed by risk reassessment.
  • Combining osteoporosis medications is not advised.

    • Impact:

    • Informs clinical decision-making for effective postmenopausal osteoporosis management.
    • Highlights the need for personalized treatment strategies based on fracture risk.
    • Provides guidance on treatment duration and the necessity of follow-up risk assessments.